CN Stock MarketDetailed Quotes

688166 Brightgene Bio-Medical Technology Co.,Ltd.

Watchlist
  • 33.20
  • -0.60-1.78%
Market Closed Dec 13 15:00 CST
14.03BMarket Cap74.61P/E (TTM)

About Brightgene Bio-Medical Technology Co.,Ltd. Company

The company is an innovative pharmaceutical company participating in international competition. Driven by research and development, the company focuses on the first imitation, difficult to replicate, specialty APIs, complex formulations and original new drugs, and continues to build a high-tech barrier, gradually establishing a business system that integrates APIs and formulations, combines generic drugs with innovative drugs, and places equal emphasis on international and domestic markets, and is committed to meeting the unmet clinical needs of patients around the world. The company has always implemented a business system that integrates APIs and formulations, combines generic drugs with innovative drugs, and places equal emphasis on the international market and domestic market. Core products in the antiviral field include entecavir, oseltamivir, etc. Core products in the field of antifungal include capofungin, micafungin sodium, anifenzin, posaconazole, etc. Core products in the field of immunosuppression include everolimus, pimemecolus, etc., and core products in the field of respiratory system include budesonide, salmetroticasone, and tiotropium bromide. Core products in the field of anti-tumor include elibulin, innovative drug BGC0228, and innovative drug BGM0504. The company has successively won honors such as “National Intellectual Property Demonstration Enterprise” (awarded by the State Intellectual Property Office), “2017 China Patent Excellence Award” (awarded by the State Intellectual Property Office), “First Prize of the 11th Chinese Pharmaceutical Society Science and Technology Award”, “2021 Science and Technology Innovation Board Top 50 Value”, etc., and was selected for the “Shanghai Science and Technology Innovation Board 50 Component Index” sample and the honorary title of “Advanced Unit for Ecological and Environmental Protection”.

Company Profile

Short Name-A博瑞生物医药
Company NameBrightGene Bio-Medical Technology Co.,Ltd.
Listing DateNov 8, 2019
Issue Price12.71
Shares Offered41.00M share(s)
FoundedOct 26, 2001
Chairmanjiandong yuan
Legal Representativejiandong yuan
General Managerjiandong yuan
Secretarynan ding
Employees1155
ProvinceJiang Su Sheng
Phone0512-62620988
Office AddressBuilding C25-C28, Nano Science Park, No. 218 Xinghu Street, Suzhou Industrial Park
Zip Code215123
Registered AddressBuilding C25, Nano Science Park, No. 218 Xinghu Street, Suzhou Industrial Park, Jiangsu
Fax0512-62551799
EmailIR@bright-gene.com
Business License91320000731789594Y
BusinessDevelop macrocyclic lactones, peptides, polysaccharides, heterocyclic, azoles, azines, phenylethers, and tetracycline compounds, produce non-pharmaceutical macrocyclic lactones, polypeptides, polysaccharides, heterocyclic, azoles, azines, phenylethers, tetracycline compounds, and provide related technical consulting and technical services (not involving the scope of pharmaceutical production license management and restricted and prohibited products in the national foreign investment industry guidance catalogue). (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • jiandong yuan
  • Chairman, Directors, General Manager
  • 1.91M
  • tong tong
  • Directors
  • --
  • xincheng shen
  • Directors
  • --
  • yinghua wu
  • Independent Directors, Member of the Remuneration and Assessment Committee, Audit Committee Convener
  • 31.90K
  • zengjiang cheng
  • Independent Directors
  • --
  • dongdong xu
  • Independent Directors, Audit Committee Members, Remuneration and Assessment Committee Convener, Nomination Committee Members
  • 31.90K
  • jingyan song
  • Securities Affairs Representative
  • --
  • xing he
  • Auditors
  • --
  • wei cha
  • Auditors
  • 285.90K
  • yingxian shen
  • Auditors
  • --
  • kai li
  • Deputy General Manager
  • 974.60K
  • yuanlai zou
  • Chief Financial Officer
  • 436.60K
  • shengwei liu
  • Core Technical Personnel
  • --
  • bingfeng wang
  • Core Technical Personnel
  • --
  • yuhuai wang
  • Core Technical Personnel
  • --
  • ming guo
  • Core Technical Personnel
  • --
  • jingfu he
  • Employee Supervisors
  • 358.50K
  • runyi gong
  • Employee Supervisors
  • --
Heat List
CN
Overall
Symbol
Price
% Chg

No Data